International Journal of Medicine and Public Health · 2013 · 11 citations · 11 references
MedicineEndocrinologyInternal MedicineDiabetologyPediatric EndocrinologyReproductive EndocrinologyDiabetes MellitusEndocrine Metabolic DisordersThyroid DisordersThyroid EndocrinologySubclinical Hyperthyroidism AssessmentSubclinical Hypothyroidism
Background: Subclinical thyroid disorders usually do not produce symptoms of thyroid disease until they turn into over thyroid disease. Thyroid disease is more common in people with diabetes mellitus than in the general population and it is important to detect thyroid disorder before its clinical manifestation. Subclinical hypothyroidism (SCH) can produce dyslipidemia, obesity thus resulting increased predisposition to coronary artery disease. Subclinical hyperthyroidism can aggravate hyperglycemia and impair blood sugar control. Objectives: Our objective is to determine the prevalence of subclinical thyroid disorders in patients with type 2 diabetes mellitus (T2DM) and to analyze the clinical and metabolic profi le of patients with this dual endocrine disorder. Methods and Results: One hundred consecutive type 2 diabetic patients without clinical manifestations of thyroid disorders were screened for SCH and subclinical hyperthyroidism using serum free T 3 , free T 4 and thyroid stimulating hormone (TSH) levels. Individuals of subclinical thyroid disease were further screened for thyroperoxidase (TPO) antibodies. SCH was detected in 13% of type 2 diabetic patients and none had subclinical hyperthyroidism in our study. SCH was common among females with type 2 diabetes (84.6%). Elevated TPO antibody levels were present in 84.6% SCH patients. Diabetic retinopathy among SCH patients showed signifi cant association with higher serum TSH levels. Left ventricular diastolic dysfunction was present in 30.8% of SCH patients. Conclusion: SCH is common among type 2 diabetic patients, especially in females. It is most commonly secondary to autoimmune thyroid disease. Microvascular complications are commonly observed in this group of patients with dual endocrinal disorder and treating physician should be aware of the impact and should routinely screen SCH to prevent complications.
11
The Colorado Thyroid Disease Prevalence Study
Gay J. Canaris, Neil Manowitz, Gilbert H. Mayor et al. · Archives of Internal Medicine · 2000 · 2.8K citations
Jennifer Hollowell · The Journal of Clinical Endocrinology & Metabolism · 2002 · 1K citations · Full text
Frequency of Thyroid Dysfunction in Diabetic Patients: Value of Annual Screening
Petros Perros, Rory J. McCrimmon, G. Shaw et al. · Diabetic Medicine · 1995 · 445 citations
Medicine, Endocrinology, Diabetology +13
José Manuel Fernández‐Real, Abel López‐Bermejo, Antoni Castro et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 166 citations · Full text